Medicinal Products

791. Deputy John Lahart asked the Minister for Health further to Parliamentary Question No. 235 of 2 October 2024, her views on whether funding earmarked for new medicines was spent on existing medicines; whether she will issue a directive to the HSE to ensure all funding earmarked for new medicines is spent exclusively for that purpose; and if she will make a statement on the matter. [25228/25]

806. Deputy David Cullinane asked the Minister for Health the number of community pharmacies that have signed up to the upcoming HRT programme proposed by her Department, by county of those who have done so. [25303/25]

808. Deputy Michael Collins asked the Minister for Health further to Parliamentary Question No. 798 of 18 February 2025, for a further update on the progression of the recommended policy regarding 'controlled drugs' Ava's protocol, as per the inquest on 5 December 2024; and if she will make a statement on the matter. [25333/25]

814. Deputy Seán Ó Fearghaíl asked the Minister for Health further to Parliamentary Question No. 177 of 18 May 2022, when voretigene neparvovec luxturna will be added to the reimbursement list in line with the Health Act 2013 and the national framework agreed with the pharmaceutical industry under which a company must submit an application to the HSE to have a new medicine approved; and if she wil…

828. Deputy Pádraig O'Sullivan asked the Minister for Health if he will make the freestyle libre 2 system available on medical card to those using both metformin and insulin; and if she will make a statement on the matter. [25471/25]

309. Deputy Niamh Smyth asked the Minister for Health if she will review correspondence (details supplied) in relation to the proposed HRT scheme; and if she will make a statement on the matter. [24913/25]

325. Deputy Claire Kerrane asked the Minister for Health further to Parliamentary Question No. 2211 of 29 April 2025, if a timeline or target exists for the provision of intravitreal injections for macular degeneration in a community setting; the specific steps which have been taken to date in actioning this recommendation from the 2018 Eye Services Review; and if she will make a statement on the …

328. Deputy John Lahart asked the Minister for Health to outline the position with regard to access to medicines by pharmacists, as indicated at a recent conference; if she is satisfied with the supply chain for all drugs; and if she will make a statement on the matter. [25002/25]

189. Deputy Jennifer Whitmore asked the Minister for Health the number of community pharmacies she has written to regarding the provision of free HRT; the uptake she has had on her offer to date, on a county-by-county basis, in tabular form; and if she will make a statement on the matter. [24629/25]

190. Deputy Jennifer Whitmore asked the Minister for Health whether her Department has provided pharmacists with a full list of medications to be covered under the free HRT scheme; and if she will make a statement on the matter. [24630/25]

191. Deputy Jennifer Whitmore asked the Minister for Health whether appropriate IT systems are in place to allow for the free HRT scheme to be rolled out efficiently, and for individual pharmacies to be reimbursed by the State in a timely manner; and if she will make a statement on the matter. [24631/25]

192. Deputy Jennifer Whitmore asked the Minister for Health if the free HRT scheme will have any impact on recipients of the drug payment scheme, in particular in instances where their selected pharmacy is not signed up to the free HRT scheme; and if she will make a statement on the matter. [24632/25]

194. Deputy Michael Cahill asked the Minister for Health the strategies in place to ensure the continuous supply of prescription drugs to pharmacies throughout the country (details supplied); and if she will make a statement on the matter. [24664/25]

113. Deputy Marie Sherlock asked the Minister for Health the action she has taken to ensure that community pharmacists will administer the free hormone replacement therapy, HRT, scheme from 1 June 2025; and if she will make a statement on the matter. [24511/25]

130. Deputy Pádraig O'Sullivan asked the Minister for Health the progress made regarding commitments in the Programme for Government surrounding rare diseases and specifically plans for a review of the drug reimbursement process, increasing the number of clinical trials and providing an early access scheme for new drug and treatment; and if she will make a statement on the matter. [23511/25]

175. Deputy Michael Cahill asked the Minister for Health if Pluvicto, the new, life-changing prostate cancer medication that has been approved by the European Medicines Agency, will be made available to all public patients at the earliest possible date; the estimated full year cost of providing this treatment; and if she will make a statement on the matter. [23673/25]

192. Deputy Shane Moynihan asked the Minister for Health to outline her engagements with the HSE on access to givinostat for Duchenne muscular dystrophy; and if she will make a statement on the matter. [23725/25]

193. Deputy Grace Boland asked the Minister for Health the work her Department has undertaken to engage with the manufacturers of HRT products to minimise any supply chain issues; and if she will make a statement on the matter. [24048/25]

201. Deputy James O'Connor asked the Minister for Health the means by which she will ensure that patients have access to new innovative medicines and treatments as quickly as possible, especially for rare diseases; and if she will make a statement on the matter. [24095/25]

1000. Deputy Richard Boyd Barrett asked the Minister for Health for an overview of the primary and secondary legislation regulating medical advertising and labelling, in particular the legislation regulating what health and medical claims sellers can make about their products. [23187/25]

1033. Deputy Michael Cahill asked the Minister for Health if she will request the HSE to make the new, life changing prostate cancer therapy, pluvicto, a treatment that has been approved by the European Medicines Agency, available to all public patients at the earliest possible date; the cost of this treatment; how soon will it be available to patients in Ireland; and if she will make a statement …

443. Deputy Peter 'Chap' Cleere asked the Minister for Health the reason evorel 50mg and estradot mg are not currently covered on GMS scheme which results in patient has to pay privately for this; and if she will make a statement on the matter. [23064/25]

414. Deputy John Brady asked the Minister for Health if there are plans to carry out an inquiry into the historical licensing and prescribing of sodium valproate; if so when this inquiry will be carried out; and if she will make a statement on the matter. [22044/25]

267. Deputy Liam Quaide asked the Minister for Health her plans to introduce a nationwide scheme to allow people return unused or out of date medication to pharmacies; and if she will make a statement on the matter. [21684/25]

2005. Deputy David Cullinane asked the Minister for Health if she accepts that the delay in delivering free HRT to women is unacceptable; the steps she has taken to deliver on commitments given; if she further accepts that failure in this areas does not rest with pharmacists; and if she will make a statement on the matter. [18692/25]